Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Reperfusion and revascularization strategies for coronary artery disease in women

Article Abstract:

A review of the literature on the treatment of coronary artery disease found that women may benefit from many of the strategies used on men, including thrombolytic drugs, percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG). Thrombolytic drugs break up the blood clots that cause most heart attacks. Thrombolytic therapy substantially reduces mortality after a heart attack in both men and women, although the reduction in mortality is not as great in women as it is in men. PTCA was initially found to be less effective in women, but this may have been because the balloons used were too big. The studies show that women have more complications during the procedure, but have a similar long-term outcome as men. The same is true for CABG; long-term survival is the same in women as in men, although fewer women may experience relief from angina. The higher complication rate in women may be a reflection of their older age.

Author: Douglas, Pamela S., Eysmann, Susan B.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1992
Women, Demographic aspects, Diseases, Thrombolytic therapy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Routine upstream initiation vs. deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: The ACUITY timing trial

Article Abstract:

A prospective, randomized trial is used to determine the optimal strategy for using the platelet glycoprotein IIb/IIIa (Gp IIb/IIIa) inhibitors in patients with moderate- and high-risk acute coronary syndromes (ACS) who are undergoing an early, invasive treatment strategy. The investigations have shown that deferring the routine upstream use of Gp IIb/IIIa inhibitors for selective administration to patients has resulted in an increase in composite ischemia that has not met the criterion for noninferiority.

Author: Moses, Jeffrey W., Stone, Gregg W., Bertrand, Michel E.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2007
Analysis, Risk factors, Glycoproteins

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Choice of Revascularization Strategy for Patients With Coronary Artery Disease

Article Abstract:

Patients with coronary artery disease that only affects one artery will probably do best with angioplasty while those with more extensive disease affecting several arteries will benefit most from bypass surgery. All patients should eliminate as many modifiable risk factors as possible and should take drugs that lower cholesterol levels.

Author: Pretre, Rene, Turina, Marko I.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2001
Health aspects

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment, Coronary heart disease, Coronary artery bypass, Transluminal angioplasty, Balloon angioplasty
Similar abstracts:
  • Abstracts: Cholesterol and coronary heart disease: Screening and treatment. Caring for confused people in the general hospital setting
  • Abstracts: Postmenopausal estrogen and prevention bias. Physical activity and the risk for heart disease and stroke in women with diabetes
  • Abstracts: The effect of warfarin on mortality and reinfarction after myocardial infarction. High time for action
  • Abstracts: Suicide risk and treatments for patients with bipolar disorder. A 25-Year-Old Woman With Bipolar Disorder
  • Abstracts: Conquering Cardiovascular Disease: Progress and Promise. Cardiovascular disease. Prospects for Cardiovascular Research
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.